EFR608 - DRUGS REGULATING CARDIOVASCULAR FUNCTIONS
Course Name | Code | Semester | Theory (hours/week) |
Application (hours/week) |
Credit | ECTS |
---|---|---|---|---|---|---|
DRUGS REGULATING CARDIOVASCULAR FUNCTIONS | EFR608 | 2nd Semester | 2 | 0 | 2 | 8 |
Prequisites | None | |||||
Course language | Turkish | |||||
Course type | Elective | |||||
Mode of Delivery | Face-to-Face | |||||
Learning and teaching strategies | Lecture Discussion Question and Answer Preparing and/or Presenting Reports Brain Storming | |||||
Instructor (s) | Assoc. Prof. Banu Cahide Tel | |||||
Course objective | To teach the pharmacology of drugs affecting cardiovascular functions | |||||
Learning outcomes |
| |||||
Course Content | 1. Antihypertansive drugs 2. Diuretic drugs 3. Peripheral vasodilators 4. Antianginal drugs 5. Drugs used in heart failure 6. Drugs affecting on cardiac rhythm 7. Anticoagulant, antiplatelet drugs and thrombolytics 8. Drugs affecting on cholesterol and lipoprotein metabolism | |||||
References | 1. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji, S.O. Kayaalp 2. Goodman & Gilman?s The Pharmacological Basis of Therapeutics, L. L. Brunton, B. A. Chabner, B. C. Knollmann 3. Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy, D. E. Golan , A. H. Tashjian Jr, E. J. Armstrong 4. Basic and Clinical Pharmacology, B.G. Katzung, S. B. Masters, A. J. Trevor 5. Rang & Dale?s Pharmacology, H. P. Rang, M. M. Dale |
Course outline weekly
Weeks | Topics |
---|---|
Week 1 | Antihypertansive drugs |
Week 2 | Antihypertansive drugs |
Week 3 | Diuretic drugs |
Week 4 | Peripheral vasodilators |
Week 5 | Antianginal drugs |
Week 6 | Drugs used in heart failure |
Week 7 | Drugs used in heart failure |
Week 8 | Midterm |
Week 9 | Drugs affecting on cardiac rhythm |
Week 10 | Drugs affecting on cardiac rhythm |
Week 11 | Anticoagulant, antiplatelet drugs and thrombolytics |
Week 12 | Drugs affecting on cholesterol and lipoprotein metabolism |
Week 13 | Literature reading about cardiovascular system drugs |
Week 14 | Discussion |
Week 15 | Preparation for Final Exam |
Week 16 | final exam |
Assesment methods
Course activities | Number | Percentage |
---|---|---|
Attendance | 0 | 0 |
Laboratory | 0 | 0 |
Application | 0 | 0 |
Field activities | 0 | 0 |
Specific practical training | 0 | 0 |
Assignments | 0 | 0 |
Presentation | 0 | 0 |
Project | 0 | 0 |
Seminar | 0 | 0 |
Midterms | 1 | 50 |
Final exam | 1 | 50 |
Total | 100 | |
Percentage of semester activities contributing grade succes | 0 | 50 |
Percentage of final exam contributing grade succes | 0 | 50 |
Total | 100 |
WORKLOAD AND ECTS CALCULATION
Activities | Number | Duration (hour) | Total Work Load |
---|---|---|---|
Course Duration (x14) | 14 | 2 | 28 |
Laboratory | 0 | 0 | 0 |
Application | 0 | 0 | 0 |
Specific practical training | 0 | 0 | 0 |
Field activities | 0 | 0 | 0 |
Study Hours Out of Class (Preliminary work, reinforcement, ect) | 14 | 7 | 98 |
Presentation / Seminar Preparation | 14 | 7 | 98 |
Project | 0 | 0 | 0 |
Homework assignment | 0 | 0 | 0 |
Midterms (Study duration) | 1 | 6 | 6 |
Final Exam (Study duration) | 1 | 10 | 10 |
Total Workload | 44 | 32 | 240 |
Matrix Of The Course Learning Outcomes Versus Program Outcomes
D.9. Key Learning Outcomes | Contrubition level* | ||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
1. Has knowledge about mechanism of actions, interactions and side effects of drugs. | X | ||||
2. Knows and applies the principles of good laboratory practice. | X | ||||
3. Has knowledge about ethics in research. | X | ||||
4. Has knowledge about ethics in the use of laboratory animals. | X | ||||
5. Has the technical skill to do basic manipulations and applications on laboratory animals. | X | ||||
6. Knows methods and procedures of preclinical drug research. | X | ||||
7. Can design and conduct a pharmacological project, analyze and conclude the data. | X | ||||
8. Can follow scientific literature and current advances in pharmacology. | X | ||||
9. Can prepare a scientific report, article and presentation in pharmacology. | X | ||||
10. Gains skills to develop international collaborations and scientific interactions. | X | ||||
11. Has knowledge about approval process of pharmaceutical products. | X | ||||
12. Gains skills to project pharmacological knowledge on behalf of public health. | X |
*1 Lowest, 2 Low, 3 Average, 4 High, 5 Highest